Today in its company sponsored RegMedNet post, Asymmetrex highlights how its AlphaSTEM technology for counting adult tissue stem cells has potential for high impact in the pharmaceutical industry. Regenerative medicine also encompasses the application of stem cell fundamentals to identify traditional small molecules and biologics drug candidates to treat disorders of aging, induce or accelerate healing of injuries, as well as treat more familiar diseases and disorders. By counting tissue stem cells for the first time, Asymmetrex’s AlphaSTEM technology can be used to identify drug candidates that cause intolerable organ and tissue failure because of toxicity against tissue stem cells. Currently, such failed drugs are not discovered until expensive animal studies or clinical trials with volunteer research subjects and patients. Such failures for safety are estimated to cost the U.S. pharmaceutical industry $4-5 billion each year. By screening out stem cell-toxic drug candidates earlier and cheaper, adopting AlphaSTEM technology is projected to save major pharmaceutical companies hundreds for millions of dollars each year, while increasing overall drug safety, and accelerating the identification of effective drugs.
Related Posts
Recent Posts
- Asymmetrex® Gives First Cell Culture Core Facility Introduction to Online Rapid Stem Cell Counting in the Institute for Applied Life Sciences at UMassAmherst
- Asymmetrex’s Introduction of Online Calculators for Determination of the Dosage of Therapeutic Stem Cells Announced as a Reformation in Stem Cell Science and Medicine
- Asymmetrex® Interviewed by Tech Company News About Plans to Introduce Online Rapid-Counting Calculators for Quantifying Therapeutic Tissue Stem Cells
- Asymmetrex®’s Kinetic Stem Cell (KSC) Counting Technology is Featured in the Parent’s Guide to Cord Blood Foundation® June Newsletter
- Asymmetrex® Presents New Developments in its Rapid Stem Cell Counting Technology at the ARMI|BioFabUSA Meeting in the Millyard on Regenerative Medicine Biomanufacturing
Tags
- Adult Stem Cells
- Announcements
- Asymmetrex News
- Biotechnology
- Immortality and Stem Cells
- Industry News
- Interview
- Kinetic Stem Cell Counting
- Online Workshop
- Regenerative Medicine
- Reports
- Stem Cell Counting
- Stem Cell Information
- Stem Cell Injections
- Stem Cell Medicine
- Stem Cell Research
- Stem Cell Technology
- Stem Cell Toxicology
- Webinar
Leave a Reply